Mukka Proteins lists at a 43% premium: Should you buy, sell, or hold the stock?
Mukka Proteins: Despite the anticipation surrounding Mukka Proteins’ Rs 224-crore public offering, it fell short of expectations. Nonetheless, upon its listing on March 7, the company’s stock soared with a 43 percent premium over its issue price. However, the grey market presented a contrasting scenario, with shares experiencing substantial triple-digit gains. This disparity highlights the…